Biodexa Pharmaceuticals Plc

Biodexa Pharmaceuticals (BDRX) has registered zero cyber incidents and zero red-flag 8-K filings over the last 90 days, indicating no acute governance or operational disruptions in our recent monitoring window. However, a clean near-term record does not preclude material risks in the broader corporate history—low signal in a 90-day window can mask longer-term patterns in dilution cycles, financing structures, and cumulative officer changes. The full $49 Report extends analysis across 12 months of SEC filings, quantifies dilution risk scores, maps financing history and terms, flags AI-driven risk signals, and contextualizes any 8-K events within the company's capital trajectory. This deeper foundation helps investors distinguish between genuine stability and temporary absence of reported events.